The latest quarterly R&D expense is $5.78 Million with a QoQ Growth of -1.77%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $5.78M.
$5.78M
$5.78 Million
Q2 FY2026 · 2026-06-30
-1.77%
vs. $5.88M prior quarter
25
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $5.78M | -1.77% | +22.04% |
| Q1 FY2026Period end 2026-03-31 | $5.88M | +8.74% | +21.04% |
| Q4 FY2025Period end 2025-12-31 | $5.41M | -3.50% | +0.41% |
| Q3 FY2025Period end 2025-09-30 | $5.61M | +18.39% | -3.48% |
| Q2 FY2025Period end 2025-06-30 | $4.74M | -2.57% | -17.21% |
| Q1 FY2025Period end 2025-03-31 | $4.86M | -9.80% | -23.98% |
| Q4 FY2024Period end 2024-12-31 | $5.39M | -7.23% | -13.93% |
| Q3 FY2024Period end 2024-09-30 | $5.81M | +1.54% | -9.35% |
| Q2 FY2024Period end 2024-06-30 | $5.72M | -10.54% | -10.52% |
| Q1 FY2024Period end 2024-03-31 | $6.40M | +2.14% | +18.69% |
| Q4 FY2023Period end 2023-12-31 | $6.26M | -2.29% | +29.81% |
| Q3 FY2023Period end 2023-09-30 | $6.41M | +0.22% | +14.12% |
| Q2 FY2023Period end 2023-06-30 | $6.39M | +18.67% | +53.87% |
| Q1 FY2023Period end 2023-03-31 | $5.39M | +11.71% | +29.08% |
| Q4 FY2022Period end 2022-12-31 | $4.82M | -14.10% | +56.32% |
| Q3 FY2022Period end 2022-09-30 | $5.62M | +35.13% | +55.48% |
| Q2 FY2022Period end 2022-06-30 | $4.16M | -0.46% | +296.94% |
| Q1 FY2022Period end 2022-03-31 | $4.17M | +35.29% | +15.59% |
| Q4 FY2021Period end 2021-12-31 | $3.09M | -14.56% | -39.26% |
| Q3 FY2021Period end 2021-09-30 | $3.61M | +244.99% | -11.64% |
| Q2 FY2021Period end 2021-06-30 | $1.05M | -71.01% | -64.47% |
| Q1 FY2021Period end 2021-03-31 | $3.61M | -28.91% | N/A |
| Q4 FY2020Period end 2020-12-31 | $5.08M | +24.29% | N/A |
| Q3 FY2020Period end 2020-09-30 | $4.09M | +38.72% | N/A |
| Q2 FY2020Period end 2020-06-30 | $2.95M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
